Prelude Therapeutics Inc (PRLD) earnings · rev $12.1M
These earnings events as JSON? API free 100/dayPrelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
This PRLD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PRLD revenue for 2025-12-31 was $12.1M. Net income was -$99.5M. Revenue was up 73.4% from 2024-12-31 to 2025-12-31. PRLD currently screens at market cap $346.5M.
When the next PRLD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 73.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PRLD research stays on the stock page; the tape stays on the quote page.
PRLD earnings FAQ
What are PRLD's latest revenue and net income?
Latest cached Prelude Therapeutics Inc (PRLD) revenue for Dec 31, 2025 was $12.1M. Net income was -$99.5M. Statements: https://lician.com/financials/prld
What is PRLD's latest diluted EPS?
Latest cached Prelude Therapeutics Inc (PRLD) diluted EPS for Dec 31, 2025 was -$1.29.
What period does the latest PRLD earnings print cover?
The latest cached Prelude Therapeutics Inc (PRLD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PRLD revenue change from the prior cached period?
Cached Prelude Therapeutics Inc (PRLD) revenue was up 73.4% from $7.0M (Dec 31, 2024) to $12.1M (Dec 31, 2025). Statements: https://lician.com/financials/prld
Where are PRLD earnings listed?
Cached earnings facts for Prelude Therapeutics Inc (PRLD) are listed at https://lician.com/earnings/prld. Statements: https://lician.com/financials/prld
Not investment advice.